Myeloablative Allogeneic Bone Marrow Transplant Using T Cell Depleted Allografts Followed by Post-Transplant GM-CSF in High Risk Myelodysplastic Syndromes

Allogeneic blood and marrow transplantation (alloBMT) remains the only curative treatment for patients with myelodysplastic syndromes (MDS), but its application has been limited by the older age range of patients with this disease. T cell depletion decreases transplant-related toxicity related to gr...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Warlick, Erica D., O'Donnell, Paul V., Borowitz, Michael, Grupka, Nichon, Decloe, Lauren, Garrett-Mayer, Elizabeth, Borrello, Ivan, Brodsky, Robert, Fuchs, Ephraim, Huff, Carol Ann, Luznik, Leo, Matsui, William, Ambinder, Richard, Jones, Richard J., Smith, B. Douglas
Format: Artigo
Jezik:Inglês
Izdano: 2008
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2719785/
https://ncbi.nlm.nih.gov/pubmed/18261793
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2007.12.017
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items